<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD001697" GROUP_ID="STROKE" ID="334399072109102043" MERGED_FROM="" MODIFIED="2010-08-30 17:38:49 +0200" MODIFIED_BY="Hazel Fraser" REVIEW_NO="0001" REVMAN_SUB_VERSION="5.0.24" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="6.0">
<COVER_SHEET MODIFIED="2010-08-30 17:38:49 +0200" MODIFIED_BY="Hazel Fraser">
<TITLE>Timing of surgery for aneurysmal subarachnoid haemorrhage</TITLE>
<CONTACT MODIFIED="2010-08-30 17:38:49 +0200" MODIFIED_BY="Hazel Fraser"><PERSON ID="16556" ROLE="AUTHOR"><PREFIX>Mr</PREFIX><FIRST_NAME>Peter</FIRST_NAME><MIDDLE_INITIALS>C</MIDDLE_INITIALS><LAST_NAME>Whitfield</LAST_NAME><SUFFIX>BM (Distinction) PhD FRCS (Neuro. Surg.)</SUFFIX><POSITION>Consultant Neurosurgeon</POSITION><EMAIL_1>peter.whitfield@brain-spine.co.uk</EMAIL_1><ADDRESS><DEPARTMENT>South West Neurosurgery Centre</DEPARTMENT><ORGANISATION>Derriford Hospital</ORGANISATION><CITY>Plymouth</CITY><ZIP>PL6 8DH</ZIP><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 1752 792540</PHONE_1><FAX_1>+44 1752 517643</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2010-08-30 17:38:49 +0200" MODIFIED_BY="Hazel Fraser"><PERSON ID="16556" ROLE="AUTHOR"><PREFIX>Mr</PREFIX><FIRST_NAME>Peter</FIRST_NAME><MIDDLE_INITIALS>C</MIDDLE_INITIALS><LAST_NAME>Whitfield</LAST_NAME><SUFFIX>BM (Distinction) PhD FRCS (Neuro. Surg.)</SUFFIX><POSITION>Consultant Neurosurgeon</POSITION><EMAIL_1>peter.whitfield@brain-spine.co.uk</EMAIL_1><ADDRESS><DEPARTMENT>South West Neurosurgery Centre</DEPARTMENT><ORGANISATION>Derriford Hospital</ORGANISATION><CITY>Plymouth</CITY><ZIP>PL6 8DH</ZIP><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 1752 792540</PHONE_1><FAX_1>+44 1752 517643</FAX_1></ADDRESS></PERSON><PERSON ID="7751" ROLE="AUTHOR"><PREFIX>Mr</PREFIX><FIRST_NAME>Peter</FIRST_NAME><LAST_NAME>Kirkpatrick</LAST_NAME><ADDRESS><DEPARTMENT>Department of Neurosurgery</DEPARTMENT><ORGANISATION>Addenbrookes Hospital</ORGANISATION><ADDRESS_1>Hills Rd</ADDRESS_1><CITY>Cambridge</CITY><ZIP>CB2 2QQ</ZIP><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 1223 245151 ext: 3214</PHONE_1><PHONE_2>+44 1223 245151 ext: 3092</PHONE_2><FAX_1>+44 1223 216926</FAX_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2010-08-30 16:23:31 +0100" MODIFIED_BY="Hazel Fraser">
<UP_TO_DATE>
<DATE DAY="15" MONTH="6" YEAR="2000"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="27" MONTH="7" YEAR="2010"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="" MONTH="" YEAR=""/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="3" YEAR="1999"/>
<REVIEW_PUBLISHED ISSUE="2" YEAR="2001"/>
<LAST_CITATION_ISSUE ISSUE="2" YEAR="2001"/>
</DATES>
<WHATS_NEW MODIFIED="2010-08-30 16:26:27 +0100" MODIFIED_BY="Hazel Fraser">
<WHATS_NEW_ENTRY EVENT="STABLE" MODIFIED="2010-08-30 16:26:27 +0100" MODIFIED_BY="Hazel Fraser">
<DATE DAY="30" MONTH="8" YEAR="2010"/>
<DESCRIPTION>
<P>The Cochrane Stroke Group Trials Register was last searched for this review on 27 July 2010. No new relevant trials were found. The Cochrane Stroke Group Editorial Board believes that it is very unlikely that there will be any further trials in this topic area.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2010-08-30 16:23:52 +0100" MODIFIED_BY="Hazel Fraser">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2010-08-30 16:23:52 +0100" MODIFIED_BY="Hazel Fraser">
<DATE DAY="30" MONTH="7" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES/>
<EXTERNAL_SOURCES/>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2008-07-30 16:02:18 +0100" MODIFIED_BY="Hazel Fraser">
<SUMMARY MODIFIED="2008-07-30 15:46:21 +0100" MODIFIED_BY="Hazel Fraser">
<TITLE MODIFIED="2008-07-30 15:46:21 +0100" MODIFIED_BY="Hazel Fraser">Timing of surgery for aneurysmal subarachnoid haemorrhage</TITLE>
<SUMMARY_BODY MODIFIED="2008-07-30 15:46:10 +0100" MODIFIED_BY="Hazel Fraser">
<P>There is no evidence on the best time for surgical treatment of aneurysmal subarachnoid haemorrhage. Aneurysmal subarachnoid haemorrhage is a life-threatening condition. It is due to the bursting of an aneurysm (a weakness in the wall of a blood vessel in the brain). This can be treated by a surgical operation to place a clip over the aneurysm neck. There is uncertainty about whether to perform the operation immediately, or to wait a few days. The review found only one randomised trial which assessed the effect of the timing of surgery. From the limited evidence available, the timing of surgery was not a critical factor in determining the outcome from an aneurysmal subarachnoid haemorrhage, but further research is needed.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT>
<ABS_BACKGROUND>
<P>The timing of surgery to secure a ruptured aneurysm after a subarachnoid haemorrhage is an important issue. Early clipping of an aneurysm prevents rebleeding, a major cause of death after a subarachnoid haemorrhage. However, concerns about the possible deleterious effects of early surgery raise questions about the safety and efficacy of this approach. This review examines the randomised controlled evidence addressing the effect of surgery at different time intervals on the outcome after a subarachnoid haemorrhage.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES>
<P>To determine whether the timing of surgery after a subarachnoid haemorrhage significantly influences overall management outcome.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY>
<P>We searched the Cochrane Stroke Review Group Trials Register and in addition searched MEDLINE, EMBASE and the Cochrane Controlled Trials Register (CENTRAL/CCTR). Colleagues were contacted to identify further studies and unpublished trials. </P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA>
<P>All completed, unconfounded, truly randomised trials comparing "best medical treatment plus early surgery" with "best medical treatment plus delayed surgery".</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION>
<P>The authors selected trials for inclusion, or exclusion, according to the above criteria. An "intention to treat" analysis strategy was utilised.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS>
<P>Only one randomised controlled trial addressing the timing of surgery after aneurysmal subarachnoid haemorrhage was identified. Patients undergoing early surgery tended to fare better than those undergoing late surgery (death or dependency at 3 months OR 0.37 95% CI 0.13,1.02). Patients undergoing surgery in the intermediate time period appeared to fare worse than those undergoing early surgery although confidence intervals were wide (death or dependency at 3 months OR 0.34 95% CI 0.12, 0.93). </P>
</ABS_RESULTS>
<ABS_CONCLUSIONS>
<P>Based upon the limited randomised controlled evidence available, the timing of surgery was not a critical factor in determining outcome following a subarachnoid haemorrhage. Since the publication of the only randomised controlled study in 1989, techniques for the treatment of subarachnoid haemorrhage have progressed, questioning the validity of the conclusions in the modern era. Currently, most neurovascular surgeons elect to operate within 3 or 4 days of the bleed in good grade patients to minimise the chances of a devastating rebleed. However, the treatment of patients in poorer grades warrants further scrutiny in a randomised controlled trial.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2008-07-30 16:02:18 +0100" MODIFIED_BY="Hazel Fraser">
<BACKGROUND MODIFIED="2008-07-30 15:56:26 +0100" MODIFIED_BY="Hazel Fraser">
<P>Historical studies have shown that without surgery 63% of patients with an aneurysmal subarachnoid haemorrhage (SAH) die within one year of the initial bleed (<LINK REF="REF-Locksley-1966" TYPE="REFERENCE">Locksley 1966</LINK>). 61% of these deaths occur within the first two weeks (<LINK REF="REF-Locksley-1966" TYPE="REFERENCE">Locksley 1966</LINK>). Over the past three decades, concurrent with the development of surgical techniques and the implementation of medical strategies, the case-fatality after SAH has improved (<LINK REF="REF-Hop-1997" TYPE="REFERENCE">Hop 1997</LINK>). </P>
<P>The principal causes of death following a subarachnoid haemorrhage are (1) a devastating initial haemorrhage, (2) rebleeding (<LINK REF="REF-Kassell-1990a" TYPE="REFERENCE">Kassell 1990a</LINK>; <LINK REF="REF-Broderick--1994" TYPE="REFERENCE">Broderick 1994</LINK>), and (3) delayed cerebral ischaemia (<LINK REF="REF-Kassell-1990a" TYPE="REFERENCE">Kassell 1990a</LINK>). Theoretical benefits of early surgery are reduction of the risk of a rebleed and the washout of cisternal blood (a possible factor in the development of cerebral ischaemia) (<LINK REF="REF-Mizukami-1982" TYPE="REFERENCE">Mizukami 1982</LINK>). Early clipping of the cerebral aneurysm allows for safer introduction of hypertensive treatment strategies aimed at the prevention and/or treatment of delayed cerebral ischaemia (<LINK REF="REF-Kosnik-1976" TYPE="REFERENCE">Kosnik 1976</LINK>). However, surgery within the first few days of a subarachnoid haemorrhage may carry an excess risk attributable to hostile operative conditions, including swollen friable brain tissue, and the disturbance of cerebral autoregulatory control (<LINK REF="REF-Kassell-1990b" TYPE="REFERENCE">Kassell 1990b</LINK>). Observational studies have also suggested that the risk of post-operative ischaemic deficits is increased when surgery occurs during the second week following a subarachnoid haemorrhage (<LINK REF="REF-Kassell-1990b" TYPE="REFERENCE">Kassell 1990b</LINK>; <LINK REF="REF-Solomon-1991" TYPE="REFERENCE">Solomon 1991</LINK>).</P>
<P>Delayed surgical intervention may reduce the morbidity and the mortality of the surgical procedure due to improvements in operating conditions and in the individual patient's general condition (<LINK REF="REF-Kassell-1990b" TYPE="REFERENCE">Kassell 1990b</LINK>). But, delaying surgery inevitably exposes the patient to a greater risk of a devastating rebleed, and may restrict the implementation of hypertensive treatments for vasospasm during the pre-operative waiting period (<LINK REF="REF-Swift-1992" TYPE="REFERENCE">Swift 1992</LINK>). The continuing dilemma is whether early surgery can be undertaken to reduce the risk of rebleeding without causing a significant deterioration in overall management outcome by inflicting excess morbidity and mortality. Several large non-randomised studies have failed to determine the optimal timing of surgery to secure a ruptured aneurysm after a subarachnoid haemorrhage (<LINK REF="REF-Chyatte-1988" TYPE="REFERENCE">Chyatte 1988</LINK>; <LINK REF="REF-Ljunggren-1988" TYPE="REFERENCE">Ljunggren 1988</LINK>; <LINK REF="REF-Kassell-1990a" TYPE="REFERENCE">Kassell 1990a</LINK>; <LINK REF="REF-Kassell-1990b" TYPE="REFERENCE">Kassell 1990b</LINK>; <LINK REF="REF-Deruty-1991" TYPE="REFERENCE">Deruty 1991</LINK>; <LINK REF="REF-Miyaoka-1993" TYPE="REFERENCE">Miyaoka 1993</LINK>; <LINK REF="REF-Krupp-1994" TYPE="REFERENCE">Krupp 1994</LINK>; <LINK REF="REF-Whitfield-1996" TYPE="REFERENCE">Whitfield 1996</LINK>; <LINK REF="REF-Maurice-1997" TYPE="REFERENCE">Maurice 1997</LINK>). </P>
<P>Therefore, this review aims to systematically search for and combine all the evidence from randomised controlled trials relating to the timing of surgery in patients with an aneurysmal subarachnoid haemorrhage.</P>
</BACKGROUND>
<OBJECTIVES>
<P>To determine the influence of the timing of aneurysm surgery on overall outcome following a subarachnoid haemorrhage.</P>
</OBJECTIVES>
<METHODS MODIFIED="2008-07-30 16:01:05 +0100" MODIFIED_BY="Hazel Fraser">
<SELECTION_CRITERIA>
<CRIT_STUDIES>
<P>Unconfounded and truly randomised trials comparing "best medical treatment plus early surgery", with the "best medical treatment plus delayed surgery".</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS>
<P>Participants must have had a recent aneurysmal subarachnoid haemorrhage.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS>
<P>Intracranial surgical procedures directed at clipping or wrapping of the ruptured intracranial aneurysm, with the aim of reducing the risk of rebleeding.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES>
<P>1. Early outcome. The Glasgow Outcome Scale, or similar, of all randomised patients at about 30 days follow-up.<BR/>2. Final outcome. The Glasgow Outcome Scale, or similar, of all randomised patients at the scheduled end of trial follow-up.<BR/>3. Deaths from any cause within the scheduled period of trial follow-up.<BR/>4. Symptomatic rebleeding confirmed by CT scan or ventricular cerebrospinal fluid analysis.<BR/>5. Neurological deterioration, defined as a decrease in the Glasgow Coma Scale, or similar, with no CT scan or ventricular CSF evidence of rebleeding as the cause, within 30 days of surgery.<BR/>6. Duration of hospital stay.<BR/>7. Quality of life/anxiety during hospital stay.</P>
<P>Where applicable (outcomes 1 and 2), a favourable outcome is defined as a good outcome or moderate disability (independent), and an unfavourable outcome as severe disability (dependent), persistent vegetative state or death, as defined by the Glasgow Outcome Scale or similar (<LINK REF="REF-Jennett-1975" TYPE="REFERENCE">Jennett 1975</LINK>).</P>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2008-07-30 16:01:05 +0100" MODIFIED_BY="Hazel Fraser">
<P>See: 'Specialized register' section in <A HREF="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/STROKE/frame.html">Cochrane Stroke Group</A>
</P>
<P>Relevant trials were identified in the Cochrane Stroke Group's Trials Register. In addition, we searched MEDLINE (<LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>), EMBASE (<LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>) and the Cochrane Controlled Trials Register (CENTRAL/CCTR) (<I>The Cochrane Library</I> Issue 4 1999) (<LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>). We sought to identify unpublished studies by consulting colleagues.</P>
</SEARCH_METHODS>
<DATA_COLLECTION>
<P>Titles and abstracts of approximately 7000 records identified by the search strategy were screened by one of the reviewers (PCW). The full text of all studies of possible relevance were obtained for independent assessment by both reviewers. The reviewers decided which trials fitted the inclusion criteria. Discrepancies between reviewers were resolved by discussion. Data extraction was performed independently by two reviewers. The authors of trials were contacted to provide missing data where possible. Data were checked and entered onto the computer by one reviewer (PCW).</P>
<P>The following potential parameters of methodological quality were assessed: the adequacy of randomisation concealment; the composition of treatment groups (matched for age, clinical grade, aneurysm location, pharmacological treatments); whether outcome assessors were blinded to the timing of surgery; the percent of patients crossing-over from the randomisation protocol; and the percent of participants in whom follow-up was completed.</P>
<P>Quantitative analyses of outcomes were based on an intention-to treat basis. If adequate data were extracted, a weighted treatment effect (using random effects) calculation across trials using the Cochrane statistical package, RevMan version 4.1 was proposed. The results were expressed as an odds ratio (OR and 95% confidence intervals (CI)) and the risk difference (RD with 95% CI) for dichotomous outcomes. Analyses were performed primarily on the long term morbidity and mortality of the early and delayed surgical intervention groups (i.e. outcome measures 1 and 2).</P>
<P>Sensitivity analyses were pre-specified on the basis of the methodological quality and to test for heterogeneity in the results. If data were available additional sub-group analyses were intended:<BR/>1. to investigate possible differences between patients aged 65 years and over with those under the age of 65, since observational studies suggest older patients may be at an increased risk of death or poor outcome (<LINK REF="REF-Muizelaar-1988" TYPE="REFERENCE">Muizelaar 1988</LINK>; <LINK REF="REF-Lanzino-1996" TYPE="REFERENCE">Lanzino 1996</LINK>).<BR/>2. to investigate the effect of clinical grade of patient at the time of randomisation on the overall outcome (<LINK REF="REF-Bailes-1990" TYPE="REFERENCE">Bailes 1990</LINK>). Grade will be defined using the World Federation of Neurological Surgeons (WFNS) (<LINK REF="REF-Teasdale-1988" TYPE="REFERENCE">Teasdale 1988</LINK>; <LINK REF="REF-Drake-1988" TYPE="REFERENCE">Drake 1988</LINK>) or Hunt and Hess (<LINK REF="REF-Hunt-1968" TYPE="REFERENCE">Hunt 1968</LINK>) scores.</P>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2008-07-30 16:02:18 +0100" MODIFIED_BY="Hazel Fraser">
<STUDY_DESCRIPTION>
<P>Only one trial was identified that fitted the inclusion criteria (<LINK REF="STD-Ohman-1989" TYPE="STUDY">Ohman 1989</LINK>). Patients were randomised into three surgical treatment groups: (i) early surgery (days 0-3), (ii) intermediate surgery (days 4-7) and (iii) late surgery (day 8 or later). Outcome was assessed 3 months following the SAH. The details of the trial are summarised in the "Characteristics of included studies" section. <BR/>
</P>
</STUDY_DESCRIPTION>
<STUDY_QUALITY>
<P>Balanced randomisation of 216 patients with Hunt and Hess Grade I - III SAH was undertaken using sealed envelopes in batches of 12 (<LINK REF="STD-Ohman-1989" TYPE="STUDY">Ohman 1989</LINK>). No reference was made as to whether the envelopes were opaque. Randomisation was performed after angiography. Data were analysed on an "intention to treat" basis. Interpretation of the results is complicated by the fact that 159 of the study population also participated in a study assessing the effect of nimodipine versus placebo upon the outcome after surgery for a subarachnoid haemorrhage. The nimodipine treated patients were evenly distributed across the three treatment groups. No reference is made as to whether the assessor of outcome was blinded to the timing of surgery. Outcome was determined 3 months following the subarachnoid haemorrhage and categorised according to a simplified Glasgow Outcome Scale as independent (good or moderate disability), dependent (severe disability or persistent vegetative state) or dead. </P>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2008-07-30 16:02:18 +0100" MODIFIED_BY="Hazel Fraser">
<P>In the one included study the three study groups were well matched for numbers of patients, sex distribution, age, concurrent illness (hypertension, diabetes, heart disease and alcohol abuse), clinical grade at time of randomisation and numbers treated with nimodipine (<LINK REF="STD-Ohman-1989" TYPE="STUDY">Ohman 1989</LINK>).</P>
<P>Five of the 216 patients randomised were subsequently excluded due to severity of the SAH (2 patients), infratentorial location of the ruptured aneurysm (2 patients) and a negative angiogram (1 patient). 71 patients were allocated to early surgery (day 0-3), 70 to intermediate surgery (day 4-7) and 70 to late surgery (day 8+). Outcome was determined 3 months after the SAH in this study. At 3 months, 65 (92%), 55 (79%) and 56 (80%) of cases were independent in the early, intermediate and late surgery groups respectively. 2 (3%), 11 (16%) and 5 (7%) were dependent in the three treatment groups. Overall case fatality rates were 6%, 6% and 13% in the early, intermediate and late surgical groups. Odds ratios between early and late surgery showed a trend for better overall outcome in patients undergoing early surgery. However, this did not attain statistical significance for any of the outcome groups assessed (see comparisons and data tables section). When death or dependency were considered together early surgery was favoured (OR 0.37, CI 0.13-1.02). Evaluation of early versus intermediate surgery (a time epoch in which vasospasm is considered to be a major risk factor) showed that although the case fatality of surgery in these groups was comparable (OR 0.99, CI 0.24, 4.10) increased numbers of patients appear to have poor (dependent) outcomes with intermediate surgery (OR 0.16, CI 0.03,0.73). Thus, when death and dependency are considered together early surgery was favoured although confidence intervals are wide (OR 0.34, CI 0.12,0.93). Early surgery also appears to lead to a larger proportion of patients having independent outcomes compared to intermediate surgery (OR 2.95, CI 1.07, 8.13). The outcomes did not significantly differ between the groups in the 79 patients treated with nimodipine (data not presented in this review since this was not a pre-analysis objective). No significant differences in outcome were observed in patients randomised to intermediate or late surgery.</P>
<P>Data concerning differences in duration of hospital stay, quality of life and long term outcome in the early, intermediate and late surgical groups were not available from the reviewed study.</P>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION>
<P>Most studies on the influence of surgical timing on the outcome after a subarachnoid haemorrhage are not randomised. The only completed, unconfounded randomised trial that our search strategy identified showed that the timing of surgery after a grade I-III SAH was not clearly a major factor that influenced the overall outcome of the condition (<LINK REF="STD-Ohman-1989" TYPE="STUDY">Ohman 1989</LINK>). The International Co-operative Trial was a prospective non-randomised cohort study (<LINK REF="REF-Kassell-1990a" TYPE="REFERENCE">Kassell 1990a</LINK>; <LINK REF="REF-Kassell-1990b" TYPE="REFERENCE">Kassell 1990b</LINK>) that identified a higher case fatality and morbidity associated with surgery in the intermediate time period. In the study included in this analysis, morbidity appeared to be increased at the expense of fewer independent outcomes in patients operated upon between 4 and 7 days after the SAH (<LINK REF="STD-Ohman-1989" TYPE="STUDY">Ohman 1989</LINK>). However, the confidence intervals were relatively wide suggesting the result should be interpreted with caution. </P>
</DISCUSSION>
<CONCLUSIONS>
<IMPLICATIONS_PRACTICE>
<P>For patients with aneurysmal SAH there is uncertainty about the balance of risks (surgical morbidity and mortality) and the potential benefits (safer introduction of aggressive treatment to augment cerebral perfusion if necessary and elimination of the risk of further haemorrhage) of early surgery to secure a ruptured intracranial aneurysm. Present evidence does not clearly identify a "safer time window" for aneurysm surgery. </P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH>
<P>Until a large multicentre prospective randomised unconfounded trial is performed, the timing of surgery is likely to be influenced by the conclusions of non-randomised studies, the opinions of individual surgeons and logistical factors. Discussions with neurosurgeons of international repute indicate that the majority now operate on good grade patients (grades I and II) within 3 or 4 days of the initial haemorrhage. Acceptable results appear to be achieved in these cases and most surgeons would be reluctant to subject good grade patients to the risk of rebleeding in a randomised trial with early and late surgical treatment arms. However, current thinking on patients with more severe SAH (grade III and perhaps grades IV and V) remains controversial. There is a need to study these patients prospectively in an unconfounded randomised trial addressing the question of timing of surgery. The most important outcomes remain a dichotomised Glasgow Outcome Scale, although neuropsychological assessments would be useful to refine the accuracy of outcome. Other important issues that require examination include patient age (do the elderly fare worse?), grade of haemorrhage (III, IV or V) and health economics (eg length of hospital stay, need for rehabilitation, numbers of patients returning to gainful employment). The situation is further complicated by recent developments in endovascular coiling procedures. The optimal technique (coiling or clipping) requires clarification in addition to the timing of the technique, which may differ for between surgery and coiling. </P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2008-07-30 15:55:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>The authors would like to thank all members of the Cochrane Stroke Group for assistance in preparing this report. We would particularly like to thank Brenda Thomas for her help in developing the literature search strategy. We thank all external peer reviewers for making constructive comments.</P>
<SUBSECTION>
<HEADING LEVEL="2">Ongoing Studies</HEADING>
<P>Any reader who knows of additional trials that we have omitted, or any on-going studies are requested to write to Mr Whitfield.</P>
</SUBSECTION>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST>
<P>The authors have published non-randomised data showing that hospital stay is reduced in patients undergoing early aneurysm surgery (<LINK REF="REF-Whitfield-1996" TYPE="REFERENCE">Whitfield 1996</LINK>). </P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2008-07-30 15:55:39 +0100" MODIFIED_BY="Hazel Fraser">
<P>Peter Kirkpatrick was the senior author and was largely responsible for the conception of the review. Abstract screening and initial data extraction were performed by Peter Whitfield. The manuscript was composed by Peter Whitfield after discussion with Peter Kirkpatrick. Both authors made subsequent amendments to the review, and both authors agreed on the final manuscript.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF/>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2008-07-30 16:03:54 +0100" MODIFIED_BY="Hazel Fraser">
<STUDIES MODIFIED="2008-07-30 16:03:54 +0100" MODIFIED_BY="Hazel Fraser">
<INCLUDED_STUDIES MODIFIED="2008-07-30 16:03:35 +0100" MODIFIED_BY="Hazel Fraser">
<STUDY DATA_SOURCE="PUB" ID="STD-Ohman-1989" MODIFIED="2008-07-30 16:03:35 +0100" MODIFIED_BY="Hazel Fraser" NAME="Ohman 1989" YEAR="1989">
<REFERENCE MODIFIED="2008-07-30 16:03:35 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ohman J, Heiskanen O</AU>
<TI>Timing of operation for ruptured supratentorial aneurysms: a prospective randomized study</TI>
<SO>Journal of Neurosurgery</SO>
<YR>1989</YR>
<VL>70</VL>
<PG>55-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2008-07-30 16:03:54 +0100" MODIFIED_BY="Hazel Fraser">
<STUDY DATA_SOURCE="PUB" ID="STD-Walter-1982" MODIFIED="2008-07-30 16:03:54 +0100" MODIFIED_BY="Hazel Fraser" NAME="Walter 1982" YEAR="1982">
<REFERENCE MODIFIED="2008-07-30 16:03:54 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Walter P, Neil-Dwyer G, Cruickshank JM</AU>
<TI>Beneficial effects of adrenergic blockade in patients with subarachnoid haemorrhage</TI>
<SO>British Medical Journal</SO>
<YR>1982</YR>
<VL>284</VL>
<PG>1661-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2008-07-30 15:56:26 +0100" MODIFIED_BY="Hazel Fraser">
<ADDITIONAL_REFERENCES MODIFIED="2008-07-30 15:56:26 +0100" MODIFIED_BY="Hazel Fraser">
<REFERENCE ID="REF-Bailes-1990" NAME="Bailes 1990" TYPE="JOURNAL_ARTICLE">
<AU>Bailes JE, Spetzler RF, Hadley MN, Baldwin HZ</AU>
<TI>Management morbidity and mortality of poor-grade aneurysm patients</TI>
<SO>Journal of Neurosurgery</SO>
<YR>1990</YR>
<VL>72</VL>
<PG>559-566</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Broderick--1994" MODIFIED="2008-07-30 15:56:06 +0100" MODIFIED_BY="Hazel Fraser" NAME="Broderick  1994" TYPE="JOURNAL_ARTICLE">
<AU>Broderick JP, Brott TG, Duldner JE, Tomsick T, Leach A</AU>
<TI>Initial and recurrent bleeding are the major causes of death following subarachnoid hemorrhage</TI>
<SO>Stroke</SO>
<YR>1994</YR>
<VL>25</VL>
<PG>1342-1347</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Chyatte-1988" NAME="Chyatte 1988" TYPE="JOURNAL_ARTICLE">
<AU>Chyatte D, Fode NC, Sundt TM Jr</AU>
<TI>Early versus late intracranial aneurysm surgery in subarachnoid hemorrhage</TI>
<SO>Journal of Neurosurgery</SO>
<YR>1988</YR>
<VL>69</VL>
<PG>326-331</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Deruty-1991" NAME="Deruty 1991" TYPE="JOURNAL_ARTICLE">
<AU>Deruty R, Mottolese C, Pelissou-Guyotat I, Soustiel JF</AU>
<TI>Management of the ruptured intracranial aneurysm - early surgery, late surgery, or modulated surgery? Personal experience based upon 468 patients admitted in two periods (1972- 1984 and 1985- 1989)</TI>
<SO>Acta Neurochirurgica</SO>
<YR>1991</YR>
<VL>113</VL>
<PG>1-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Drake-1988" NAME="Drake 1988" TYPE="JOURNAL_ARTICLE">
<AU>Drake CG</AU>
<TI>Report of World Federation of Neurological Surgeons Committee on a universal subarachnoid hemorrhage scale</TI>
<SO>Journal of Neurosurgery</SO>
<YR>1988</YR>
<VL>68</VL>
<PG>985-986</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hop-1997" NAME="Hop 1997" TYPE="JOURNAL_ARTICLE">
<AU>Hop JW, Rinkel GJE, Algra A, van Gijn J</AU>
<TI>Case-fatality rates and functional outcome after subarachnoid haemorrhage. A systematic review</TI>
<SO>Stroke</SO>
<YR>1997</YR>
<VL>28</VL>
<PG>660-664</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hunt-1968" NAME="Hunt 1968" TYPE="JOURNAL_ARTICLE">
<AU>Hunt WE, Hess RM</AU>
<TI>Surgical risk as related to time of intervention in the repair of intracranial aneurysms</TI>
<SO>Journal of Neurosurgery</SO>
<YR>1968</YR>
<VL>28</VL>
<PG>14-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jennett-1975" NAME="Jennett 1975" TYPE="JOURNAL_ARTICLE">
<AU>Jennett B, Bond M</AU>
<TI>Assessment of outcome after severe brain damage. A practical scale</TI>
<SO>Lancet</SO>
<YR>1975</YR>
<VL>1</VL>
<PG>480-484</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kassell-1990a" NAME="Kassell 1990a" TYPE="JOURNAL_ARTICLE">
<AU>Kassell NF, Torner JC, Haley EC Jr, Jane JA, Adams HP, Kongable GL</AU>
<TI>The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1: Overall management results</TI>
<SO>Journal of Neurosurgery</SO>
<YR>1990</YR>
<VL>73</VL>
<PG>18-36</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kassell-1990b" MODIFIED="2008-07-30 15:56:11 +0100" MODIFIED_BY="Hazel Fraser" NAME="Kassell 1990b" TYPE="JOURNAL_ARTICLE">
<AU>Kassell NF, Torner JC, Jane JA, Haley EC Jr, Adams HP</AU>
<TI>The International Cooperative Study on the Timing of Aneurysm Surgery. Part 2: Surgical results</TI>
<SO>Journal of Neurosurgery</SO>
<YR>1990</YR>
<VL>73</VL>
<PG>37-47</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kosnik-1976" NAME="Kosnik 1976" TYPE="JOURNAL_ARTICLE">
<AU>Kosnik EJ, Hunt WE</AU>
<TI>Postoperative hypertension in the management of patients with intracranial arterial aneurysms</TI>
<SO>Journal of Neurosurgery</SO>
<YR>1976</YR>
<VL>45</VL>
<PG>148-154</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Krupp-1994" NAME="Krupp 1994" TYPE="JOURNAL_ARTICLE">
<AU>Krupp W, Heienbrok W, Muke R, Heros RC, Piepgras DG</AU>
<TI>Management results attained by predominantly late surgery for intracranial aneurysms</TI>
<SO>Neurosurgery</SO>
<YR>1994</YR>
<VL>34</VL>
<PG>227-234</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lanzino-1996" NAME="Lanzino 1996" TYPE="JOURNAL_ARTICLE">
<AU>Lanzino G, Kassell NF, Germanson TP, Kongable GL, Truskowski LL, Torner JC, Jane JA, Spetzler RF, Zabramski J, Culicchia F, Carter LP, Feinberg W, Urbina C, Lopez L, Brown D, Tallman D, Selman WR, Harrington F, Warf B</AU>
<TI>Age and outcome after aneurysmal subarachnoid hemorrhage: Why do older patients fare worse?</TI>
<SO>Journal of Neurosurgery</SO>
<YR>1996</YR>
<VL>85</VL>
<PG>410-418</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ljunggren-1988" NAME="Ljunggren 1988" TYPE="JOURNAL_ARTICLE">
<AU>Ljunggren B, Fodstad H, Von Essen C, Saveland H, Brandt L, Hillman J, Romner B, Algers G</AU>
<TI>Aneurysmal subarachnoid haemorrhage: Overall outcome and incidence of early recurrent haemorrhage despite a policy of acute stage operation</TI>
<SO>British Journal of Neurosurgery</SO>
<YR>1988</YR>
<VL>2</VL>
<PG>49-53</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Locksley-1966" MODIFIED="2008-07-30 15:56:13 +0100" MODIFIED_BY="Hazel Fraser" NAME="Locksley 1966" TYPE="JOURNAL_ARTICLE">
<AU>Locksley HB</AU>
<TI>Report on the Cooperative Study on intracranial aneurysms and subarachnoid hemorrhage. Section V Part II. Natural history of subarachnoid hemorrhage, intracranial aneurysms and arteriovenous malformations. Based on 6038 cases in the Cooperative Study</TI>
<SO>Journal of Neurosurgery</SO>
<YR>1966</YR>
<VL>35</VL>
<PG>321-368</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Maurice-1997" MODIFIED="2008-07-30 15:56:26 +0100" MODIFIED_BY="Hazel Fraser" NAME="Maurice 1997" TYPE="JOURNAL_ARTICLE">
<AU>Maurice-Williams RS, Wadley JP</AU>
<TI>Delayed surgery for ruptured intracranial aneurysms: A reappraisal</TI>
<SO>British Journal of Neurosurgery</SO>
<YR>1997</YR>
<VL>11</VL>
<PG>104-109</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Miyaoka-1993" NAME="Miyaoka 1993" TYPE="JOURNAL_ARTICLE">
<AU>Miyaoka M, Sato K, Ishii S</AU>
<TI>A clinical study of the relationship of timing to outcome of surgery for ruptured cerebral aneurysms. A retrospective analysis of 1622 cases</TI>
<SO>Journal of Neurosurgery</SO>
<YR>1993</YR>
<VL>79</VL>
<PG>373-378</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mizukami-1982" NAME="Mizukami 1982" TYPE="JOURNAL_ARTICLE">
<AU>Mizukami M, Kawase T, Usami T, Tazawa T</AU>
<TI>Prevention of vasospasm by early operation with removal of subarachnoid blood</TI>
<SO>Neurosurgery</SO>
<YR>1982</YR>
<VL>10</VL>
<PG>301-307</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Muizelaar-1988" NAME="Muizelaar 1988" TYPE="JOURNAL_ARTICLE">
<AU>Muizelaar JP, Vermeulen M, Van Crevel H, Hijdra A, Van Gijn J, Teasdale GM, Lindsay KW, Murray GD</AU>
<TI>Outcome of aneurysmal subarachnoid hemorrhage in patients 66 years of age and older</TI>
<SO>Clinical Neurology &amp; Neurosurgery</SO>
<YR>1988</YR>
<VL>90</VL>
<PG>203-207</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Solomon-1991" NAME="Solomon 1991" TYPE="JOURNAL_ARTICLE">
<AU>Solomon RA, Onesti ST, Klebanoff L</AU>
<TI>Relationship between the timing of aneurysm surgery and the development of delayed cerebral ischemia</TI>
<SO>Journal of Neurosurgery</SO>
<YR>1991</YR>
<VL>75</VL>
<PG>56-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Swift-1992" NAME="Swift 1992" TYPE="JOURNAL_ARTICLE">
<AU>Swift DM, Solomon RA</AU>
<TI>Unruptured aneurysms and postoperative volume expansion</TI>
<SO>Journal of Neurosurgery</SO>
<YR>1992</YR>
<VL>77</VL>
<PG>908-910</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Teasdale-1988" NAME="Teasdale 1988" TYPE="JOURNAL_ARTICLE">
<AU>Teasdale GM</AU>
<TI>A universal subarachnoid haemorrhage scale: report of a committee of the World Federation of Neurosurgical Societies</TI>
<SO>Journal of Neurology, Neurosurgery &amp; Psychiatry</SO>
<YR>1988</YR>
<VL>51</VL>
<PG>1457</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Whitfield-1996" NAME="Whitfield 1996" TYPE="JOURNAL_ARTICLE">
<AU>Whitfield PC, Moss H, O'Hare D, Smielewski P, Pickard JD, Kirkpatrick PJ</AU>
<TI>An audit of aneurysmal subarachnoid haemorrhage: Earlier resuscitation and surgery reduces inpatient stay and deaths from rebleeding</TI>
<SO>Journal of Neurology, Neurosurgery &amp; Psychiatry</SO>
<YR>1996</YR>
<VL>60</VL>
<PG>301-306</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES/>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES>
<CHARACTERISTICS_OF_INCLUDED_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR STUDY_ID="STD-Ohman-1989">
<CHAR_METHODS>
<P>Randomised<BR/>3 months follow-up<BR/>79 patients<BR/>received nimodipine<BR/>sealed envelopes ?opaque<BR/>Intention to treat analysis</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>n = 211<BR/>Grade I-III SAH<BR/>Supratentorial aneurysm</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Surgery day 0-3<BR/>Surgery day 4-7<BR/>Surgery day 8+<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Dichotomised Glasgow Outcome Scale</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>5 patients excluded because did not fit entry criteria to study</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES SORT_BY="STUDY">
<EXCLUDED_CHAR STUDY_ID="STD-Walter-1982">
<CHAR_REASON_FOR_EXCLUSION>
<P>Published methodology and results incomplete. Study confounded by use of propranolol.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" NO="1">
<NAME>Adequate sequence generation?</NAME>
<DESCRIPTION>
<P>Was the allocation sequence adequately generated?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" NO="2">
<NAME>Allocation concealment?</NAME>
<DESCRIPTION>
<P>Was allocation adequately concealed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" NO="3">
<NAME>Blinding?</NAME>
<DESCRIPTION>
<P>Was knowledge of the allocated interventions adequately prevented during the study?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" NO="4">
<NAME>Incomplete outcome data addressed?</NAME>
<DESCRIPTION>
<P>Were incomplete outcome data adequately addressed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" NO="5">
<NAME>Free of selective reporting?</NAME>
<DESCRIPTION>
<P>Are reports of the study free of suggestion of selective outcome reporting?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Free of other bias?</NAME>
<DESCRIPTION>
<P>Was the study apparently free of other problems that could put it at a high risk of bias?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES">
<COMPARISON ID="CMP-001" NO="1">
<NAME>Early vs late surgery</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.3813417792492695" CI_START="0.11853425677688142" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.4046434494195688" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="9" I2="0.0" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="0.14030114742543312" LOG_CI_START="-0.9261561190282769" LOG_EFFECT_SIZE="-0.3929274858014219" METHOD="MH" NO="1" P_CHI2="1.0" P_Q="0.0" P_Z="0.14866430531081512" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="71" TOTAL_2="70" WEIGHT="100.0" Z="1.4442655039850825">
<NAME>Death by 3 months</NAME>
<GROUP_LABEL_1>Early surgery</GROUP_LABEL_1>
<GROUP_LABEL_2>Late surgery</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.3813417792492693" CI_START="0.11853425677688142" EFFECT_SIZE="0.4046434494195688" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="9" LOG_CI_END="0.14030114742543304" LOG_CI_START="-0.9261561190282769" LOG_EFFECT_SIZE="-0.3929274858014219" ORDER="9922" O_E="0.0" SE="0.6264422773635175" STUDY_ID="STD-Ohman-1989" TOTAL_1="71" TOTAL_2="70" VAR="0.3924299268683903" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="2.0106204065397892" CI_START="0.0706184902251563" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.37681159420289856" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" I2="0.0" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="0.3033300860586898" LOG_CI_START="-1.1510815715915645" LOG_EFFECT_SIZE="-0.42387574276643736" METHOD="MH" NO="2" P_CHI2="1.0" P_Q="0.0" P_Z="0.2532756693337439" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="71" TOTAL_2="70" WEIGHT="100.0" Z="1.1424292226653225">
<NAME>Dependent by 3 months</NAME>
<GROUP_LABEL_1>Early surgery</GROUP_LABEL_1>
<GROUP_LABEL_2>Late surgery</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.0106204065397892" CI_START="0.0706184902251563" EFFECT_SIZE="0.37681159420289856" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.3033300860586898" LOG_CI_START="-1.1510815715915645" LOG_EFFECT_SIZE="-0.42387574276643736" ORDER="9923" O_E="0.0" SE="0.854328607157576" STUDY_ID="STD-Ohman-1989" TOTAL_1="71" TOTAL_2="70" VAR="0.7298773690078038" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="7.51784125544425" CI_START="0.9756882587980361" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="2.7083333333333335" ESTIMABLE="YES" EVENTS_1="65" EVENTS_2="56" I2="0.0" I2_Q="0.0" ID="CMP-001.03" LOG_CI_END="0.8760931510382794" LOG_CI_START="-0.010688921175780476" LOG_EFFECT_SIZE="0.43270211493124955" METHOD="MH" NO="3" P_CHI2="1.0" P_Q="0.0" P_Z="0.05578458375949056" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="71" TOTAL_2="70" WEIGHT="100.0" Z="1.9127147195976295">
<NAME>Independent by 3 months</NAME>
<GROUP_LABEL_1>Early surgery</GROUP_LABEL_1>
<GROUP_LABEL_2>Late Surgery</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="7.51784125544425" CI_START="0.9756882587980361" EFFECT_SIZE="2.7083333333333335" ESTIMABLE="YES" EVENTS_1="65" EVENTS_2="56" LOG_CI_END="0.8760931510382794" LOG_CI_START="-0.010688921175780476" LOG_EFFECT_SIZE="0.43270211493124955" ORDER="9924" O_E="0.0" SE="0.5209001788605916" STUDY_ID="STD-Ohman-1989" TOTAL_1="71" TOTAL_2="70" VAR="0.2713369963369963" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.0249175297363051" CI_START="0.13301690818169679" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.36923076923076925" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="14" I2="0.0" I2_Q="0.0" ID="CMP-001.04" LOG_CI_END="0.010688921175780451" LOG_CI_START="-0.8760931510382794" LOG_EFFECT_SIZE="-0.43270211493124955" METHOD="MH" NO="4" P_CHI2="1.0" P_Q="0.0" P_Z="0.05578458375949056" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="71" TOTAL_2="70" WEIGHT="100.0" Z="1.9127147195976295">
<NAME>Death or dependency at 3 months</NAME>
<GROUP_LABEL_1>Early surgery</GROUP_LABEL_1>
<GROUP_LABEL_2>Late surgery</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.0249175297363051" CI_START="0.13301690818169679" EFFECT_SIZE="0.36923076923076925" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="14" LOG_CI_END="0.010688921175780451" LOG_CI_START="-0.8760931510382794" LOG_EFFECT_SIZE="-0.43270211493124955" ORDER="9925" O_E="0.0" SE="0.5209001788605916" STUDY_ID="STD-Ohman-1989" TOTAL_1="71" TOTAL_2="70" VAR="0.2713369963369963" WEIGHT="100.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" NO="2">
<NAME>Early vs intermediate surgery</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="4.1039131178418495" CI_START="0.23645042978025757" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.9850746268656716" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" I2="0.0" I2_Q="0.0" ID="CMP-002.01" LOG_CI_END="0.6131981579416579" LOG_CI_START="-0.6262598922595735" LOG_EFFECT_SIZE="-0.00653086715895778" METHOD="MH" NO="1" P_CHI2="1.0" P_Q="0.0" P_Z="0.9835211732674596" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="71" TOTAL_2="70" WEIGHT="100.0" Z="0.020654615002572284">
<NAME>Death by 3 months</NAME>
<GROUP_LABEL_1>Early surgery</GROUP_LABEL_1>
<GROUP_LABEL_2>Intermediate surgery</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="4.1039131178418495" CI_START="0.23645042978025757" EFFECT_SIZE="0.9850746268656716" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.6131981579416579" LOG_CI_START="-0.6262598922595735" LOG_EFFECT_SIZE="-0.00653086715895778" ORDER="9926" O_E="0.0" SE="0.7280637941045026" STUDY_ID="STD-Ohman-1989" TOTAL_1="71" TOTAL_2="70" VAR="0.5300768882858435" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.7297036861273591" CI_START="0.03312332476117636" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.15546772068511205" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="11" I2="0.0" I2_Q="0.0" ID="CMP-002.02" LOG_CI_END="-0.1368534598858439" LOG_CI_START="-1.4798660772928658" LOG_EFFECT_SIZE="-0.8083597685893548" METHOD="MH" NO="2" P_CHI2="1.0" P_Q="0.0" P_Z="0.01830421611679293" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="71" TOTAL_2="70" WEIGHT="100.0" Z="2.359406028582535">
<NAME>Dependent by 3 months</NAME>
<GROUP_LABEL_1>Early surgery</GROUP_LABEL_1>
<GROUP_LABEL_2>Intermediate surgery</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.7297036861273589" CI_START="0.03312332476117636" EFFECT_SIZE="0.155467720685112" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="11" LOG_CI_END="-0.13685345988584405" LOG_CI_START="-1.4798660772928658" LOG_EFFECT_SIZE="-0.8083597685893549" ORDER="9927" O_E="0.0" SE="0.7888922594845585" STUDY_ID="STD-Ohman-1989" TOTAL_1="71" TOTAL_2="70" VAR="0.6223509970746521" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="8.13282327857298" CI_START="1.073346677281655" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="2.954545454545454" ESTIMABLE="YES" EVENTS_1="65" EVENTS_2="55" I2="0.0" I2_Q="0.0" ID="CMP-002.03" LOG_CI_END="0.9102413354411243" LOG_CI_START="0.030740016200174164" LOG_EFFECT_SIZE="0.4704906758206493" METHOD="MH" NO="3" P_CHI2="1.0" P_Q="0.0" P_Z="0.03599606221286708" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="71" TOTAL_2="70" WEIGHT="100.0" Z="2.0969719078221183">
<NAME>Independent by 3 months</NAME>
<GROUP_LABEL_1>Early surgery</GROUP_LABEL_1>
<GROUP_LABEL_2>Intermediate surgery</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="8.13282327857298" CI_START="1.073346677281655" EFFECT_SIZE="2.9545454545454546" ESTIMABLE="YES" EVENTS_1="65" EVENTS_2="55" LOG_CI_END="0.9102413354411243" LOG_CI_START="0.030740016200174164" LOG_EFFECT_SIZE="0.4704906758206493" ORDER="9928" O_E="0.0" SE="0.5166234285238784" STUDY_ID="STD-Ohman-1989" TOTAL_1="71" TOTAL_2="70" VAR="0.2668997668997669" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.9316654359359346" CI_START="0.12295853060457305" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.3384615384615385" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="15" I2="0.0" I2_Q="0.0" ID="CMP-002.04" LOG_CI_END="-0.030740016200174178" LOG_CI_START="-0.9102413354411244" LOG_EFFECT_SIZE="-0.4704906758206493" METHOD="MH" NO="4" P_CHI2="1.0" P_Q="0.0" P_Z="0.03599606221286708" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="71" TOTAL_2="70" WEIGHT="100.0" Z="2.0969719078221183">
<NAME>Death or dependency at 3 months</NAME>
<GROUP_LABEL_1>Early surgery</GROUP_LABEL_1>
<GROUP_LABEL_2>Intermediate surgery</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.9316654359359346" CI_START="0.12295853060457305" EFFECT_SIZE="0.3384615384615385" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="15" LOG_CI_END="-0.030740016200174178" LOG_CI_START="-0.9102413354411244" LOG_EFFECT_SIZE="-0.4704906758206493" ORDER="9929" O_E="0.0" SE="0.5166234285238784" STUDY_ID="STD-Ohman-1989" TOTAL_1="71" TOTAL_2="70" VAR="0.2668997668997669" WEIGHT="100.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" NO="3">
<NAME>Intermediate vs late surgery</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.4027672948268366" CI_START="0.12028767506152457" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.4107744107744108" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="9" I2="0.0" I2_Q="0.0" ID="CMP-003.01" LOG_CI_END="0.14698563185887265" LOG_CI_START="-0.9197788691438009" LOG_EFFECT_SIZE="-0.3863966186424641" METHOD="MH" NO="1" P_CHI2="1.0" P_Q="0.0" P_Z="0.1556509903103321" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="70" TOTAL_2="70" WEIGHT="99.99999999999999" Z="1.4198512522219555">
<NAME>Death by 3 months</NAME>
<GROUP_LABEL_1>Intermediate surgery</GROUP_LABEL_1>
<GROUP_LABEL_2>Late surgery</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.4027672948268366" CI_START="0.12028767506152457" EFFECT_SIZE="0.4107744107744108" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="9" LOG_CI_END="0.14698563185887265" LOG_CI_START="-0.9197788691438009" LOG_EFFECT_SIZE="-0.3863966186424641" ORDER="9930" O_E="0.0" SE="0.6266227484584143" STUDY_ID="STD-Ohman-1989" TOTAL_1="70" TOTAL_2="70" VAR="0.3926560688855771" WEIGHT="99.99999999999999"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="7.386351813767265" CI_START="0.7953129650185897" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="2.4237288135593227" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="5" I2="0.0" I2_Q="0.0" ID="CMP-003.02" LOG_CI_END="0.868429989361398" LOG_CI_START="-0.09946193771556258" LOG_EFFECT_SIZE="0.38448402582291774" METHOD="MH" NO="2" P_CHI2="1.0" P_Q="0.0" P_Z="0.11943566783675853" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="70" TOTAL_2="70" WEIGHT="99.99999999999999" Z="1.5571466651647512">
<NAME>Dependent by 3 months</NAME>
<GROUP_LABEL_1>Intermediate surgery</GROUP_LABEL_1>
<GROUP_LABEL_2>Late surgery</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="7.386351813767265" CI_START="0.7953129650185896" EFFECT_SIZE="2.4237288135593222" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="5" LOG_CI_END="0.868429989361398" LOG_CI_START="-0.09946193771556265" LOG_EFFECT_SIZE="0.38448402582291763" ORDER="9931" O_E="0.0" SE="0.5685445091073162" STUDY_ID="STD-Ohman-1989" TOTAL_1="70" TOTAL_2="70" VAR="0.32324285883607917" WEIGHT="99.99999999999999"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="2.0768859622333062" CI_START="0.40458541925634406" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.9166666666666666" ESTIMABLE="YES" EVENTS_1="55" EVENTS_2="56" I2="0.0" I2_Q="0.0" ID="CMP-003.03" LOG_CI_END="0.3174126509248602" LOG_CI_START="-0.3929897727036598" LOG_EFFECT_SIZE="-0.0377885608893998" METHOD="MH" NO="3" P_CHI2="1.0" P_Q="0.0" P_Z="0.8348281078067428" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="70" TOTAL_2="70" WEIGHT="100.00000000000001" Z="0.20851341692367814">
<NAME>Independent by 3 months</NAME>
<GROUP_LABEL_1>Intermediate surgery</GROUP_LABEL_1>
<GROUP_LABEL_2>Late surgery</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.0768859622333062" CI_START="0.40458541925634406" EFFECT_SIZE="0.9166666666666666" ESTIMABLE="YES" EVENTS_1="55" EVENTS_2="56" LOG_CI_END="0.3174126509248602" LOG_CI_START="-0.3929897727036598" LOG_EFFECT_SIZE="-0.0377885608893998" ORDER="9932" O_E="0.0" SE="0.41729390018810375" STUDY_ID="STD-Ohman-1989" TOTAL_1="70" TOTAL_2="70" VAR="0.1741341991341991" WEIGHT="100.00000000000001"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="2.4716659385255872" CI_START="0.4814900857265582" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="1.0909090909090908" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="14" I2="0.0" I2_Q="0.0" ID="CMP-003.04" LOG_CI_END="0.39298977270365976" LOG_CI_START="-0.3174126509248602" LOG_EFFECT_SIZE="0.037788560889399754" METHOD="MH" NO="4" P_CHI2="1.0" P_Q="0.0" P_Z="0.834828107806743" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="70" TOTAL_2="70" WEIGHT="100.00000000000001" Z="0.20851341692367784">
<NAME>Death or dependency at 3 months</NAME>
<GROUP_LABEL_1>Intermediate surgery</GROUP_LABEL_1>
<GROUP_LABEL_2>Late surgery</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.4716659385255872" CI_START="0.4814900857265582" EFFECT_SIZE="1.0909090909090908" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="14" LOG_CI_END="0.39298977270365976" LOG_CI_START="-0.3174126509248602" LOG_EFFECT_SIZE="0.037788560889399754" ORDER="9933" O_E="0.0" SE="0.41729390018810375" STUDY_ID="STD-Ohman-1989" TOTAL_1="70" TOTAL_2="70" VAR="0.1741341991341991" WEIGHT="100.00000000000001"/>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES/>
<FEEDBACK/>
<APPENDICES MODIFIED="2008-07-30 15:54:29 +0100" MODIFIED_BY="Hazel Fraser">
<APPENDIX ID="APP-01" MODIFIED="2008-07-30 15:54:29 +0100" MODIFIED_BY="Hazel Fraser" NO="1">
<TITLE MODIFIED="2008-07-30 15:51:06 +0100" MODIFIED_BY="Hazel Fraser">MEDLINE search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2008-07-30 15:54:29 +0100" MODIFIED_BY="Hazel Fraser">
<P>MEDLINE (1966 - January 2000) and Cochrane Controlled Trials search strategy</P>
<P>1 cerebral aneurysm/su (subheading surgery)<BR/>2 exp cerebral hemorrhage/su<BR/>3 aneurysm/su or aneurysm, ruptured/su or aneurysm, dissecting/su<BR/>4 exp brain/ or exp carotid arteries/ or basilar artery/ or exp carotid artery diseases/ or cerebral arteries/<BR/>5 3 and 4<BR/>6 cerebral aneurysm/ or exp cerebral hemorrhage/<BR/>7 aneurysm/ or aneurysm, ruptured/ or aneurysm, disssecting/<BR/>8 4 and 7<BR/>9 (brain$ or cerebral or intracerebral or intracranial or cerebell$ or intraventricular or parenchymal or infratentorial or supratentorial or subarachnoid or carotid or communicating or giant or basilar).tw.<BR/>10 (aneurysm$ or hemorrhage$ or haemorrhage$ or hematoma$ or haematoma$ or bleed$).tw.<BR/>11 9 adj10 10<BR/>12 surgery/ or surgical procedures, operative/ or neurosurgery/ or neurosurgical procedures/ or craniotomy/<BR/>13 Cerebral revascularization/ or Vascular surgical procedures/<BR/>14 (surg$ or neurosurg$ or clip$ or wrap$ or ligation or craniotomy or by?pass).tw.<BR/>15 12 or 13 or 14<BR/>16 6 or 8 or 11<BR/>17 15 and 16<BR/>18 1 or 2 or 5 or 17<BR/>19 randomized controlled trial.pt.<BR/>20 randomized controlled trials/<BR/>21 controlled clinical trial.pt.<BR/>22 controlled clinical trials/<BR/>23 random allocation/<BR/>24 clinical trial.pt.<BR/>25 exp clinical trials/<BR/>26 (clin$ adj25 trial$).tw.<BR/>27 random$.tw.<BR/>28 research design/<BR/>29 clinical trial phase ii.pt.<BR/>30 clinical trial phase iii.pt.<BR/>31 clinical trial phase iv.pt.<BR/>32 intervention studies/<BR/>33 control$.tw.<BR/>34 "comparative study"/<BR/>35 Prospective studies/<BR/>36 prospective.tw.<BR/>37 versus.tw.<BR/>38 (conservative adj5 (treat$ or manage$ or procedure$)).tw.<BR/>39 early surgery.tw<BR/>40 ((late or delay$) adj5 surgery).tw<BR/>41 timing of surgery.tw<BR/>42 or/19-41<BR/>43 18 and 42<BR/>44 limit 43 to human</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2008-07-30 15:52:00 +0100" MODIFIED_BY="Hazel Fraser" NO="2">
<TITLE MODIFIED="2008-07-30 15:51:14 +0100" MODIFIED_BY="Hazel Fraser">EMBASE search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2008-07-30 15:52:00 +0100" MODIFIED_BY="Hazel Fraser">
<P>EMBASE search (1980 - January 2000)</P>
<P>1 brain artery aneurysm/su or brain artery aneurysm rupture/su or intracranial aneurysm/su<BR/>2 exp brain hemorrhage/su or exp brain hematoma/su or exp carotid artery aneurysm/su<BR/>3 1 or 2<BR/>4 aneurysm/su or aneurysm rupture/su or dissecting aneurysm/su<BR/>5 exp brain/ or exp brain artery/ or exp carotid artery/ or exp carotid artery disease/<BR/>6 4 and 5<BR/>7 Brain artery aneurysm/ or Brain artery aneurysm rupture/ or Intracranial aneurysm/<BR/>8 exp brain hemorrhage/ or exp brain hematoma/ or exp carotid artery aneurysm/<BR/>9 aneurysm/ or aneurysm rupture/ or dissecting aneurysm/<BR/>10 5 and 9<BR/>11 (brain$ or cerebral or intracerebral or intracranial or cerebell$ or intraventricular or parenchymal or infratentorial or supratentorial or subarachnoid or carotid or communicating or giant or basilar).tw.<BR/>12 (aneurysm$ or hemorrhage$ or haemorrhage$ or hematoma$ or haematoma$ or bleed$).tw.<BR/>13 ((brain$ or cerebral or intracerebral or intracranial or cerebell$ or intraventricular or parenchymal or infratentorial or supratentorial or subarachnoid or carotid or communicating or giant or basilar) adj10 (aneurysm$ or hemorrhage$ or haemorrhage$ or hematoma$ or haematoma$ or bleed$)).tw.<BR/>14 7 or 8 or 10 or 13<BR/>15 aneurysm surgery/ or aneurysm clip/ or artery surgery/ or exp cerebrovascular surgery/ or carotid artery surgery/ or neurosurgery/ or skull surgery/ or craniotomy/<BR/>16 (surg$ or neurosurg$ or clip$ or wrap$ or ligation or craniotomy or by?pass).tw.<BR/>17 extraintracranial anastomosis/ or revascularization/ or endovascular surgery/ or vascular surgery/ or surgical technique/ or surgery/<BR/>18 15 or 16 or 17<BR/>19 14 and 18<BR/>20 3 or 6 or 19<BR/>21 Clinical trial/<BR/>22 multicenter study/<BR/>23 phase 2 clinical trial/<BR/>24 phase 3 clinical trial/<BR/>25 phase 4 clinical trial/<BR/>26 randomized controlled trial/<BR/>27 controlled study/<BR/>28 meta analysis/<BR/>29 randomization/<BR/>30 major clinical study/<BR/>31 clinical study/<BR/>32 "0197".tg.<BR/>33 "0150".tg.<BR/>34 (clin$ adj25 trial$).tw.<BR/>35 random$.tw.<BR/>36 control$.tw.<BR/>37 Longitudinal study/<BR/>38 Prospective study/<BR/>39 "Evaluation and follow up"/ or Follow up/<BR/>40 versus.tw.<BR/>41 experimental group.tw.<BR/>42 prospective.tw.<BR/>43 (conservative adj5 (treat$ or manage$ or procedure$)).tw.<BR/>44 ((early or late or delay$) adj5 surgery).tw.<BR/>45 timing of surgery.tw.<BR/>46 Time/<BR/>47 or/21-46<BR/>48 20 and 47<BR/>49 limit 48 to human</P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS/>
</COCHRANE_REVIEW>